13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001325083
Total reported value
$179.3M
$179.3M
36 檔
71.4%
According to the latest 13F quarterly dataset, Knoll Capital Management, LLC managed an equity portfolio of $179.3M at the end of Q3 2024, spanning 36 distinct U.S. exchange-listed positions.
Knoll Capital Management, LLC executed strategic sector rebalancing during Q3 2024, establishing 2 new positions while fully exiting 1 holdings and trimming 6 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | APLT | Applied Therapeutics Inc | Stock-Other | 22.80% | — | — | |
| 2 | BHVN | Biohaven Ltd. | Stock-Other | 17.08% | -10.93% | — | |
| 3 | ALDX | Aldeyra Therapeutics Inc | Stock-Other | 14.20% | +1.36% | — | |
| 4 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 3.79% | — | — | |
| 5 | GLD | Spdr Gold Shares | ETF-Commodities | 3.74% | — | — | |
| 6 | ✓ | Entera Bio LTD | Stock-Other | 3.55% | +2.22% | — | |
| 7 | ✓ | Hookipa Pharma | Stock-Other | 3.46% | — | -90.00% | |
| 8 | ALT | Altimmune Inc | Stock-Other | 3.31% | — | — | |
| 9 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 2.77% | — | — | |
| 10 | SEA1EUR | Seabridge Gold Inc | Stock-Other | 2.56% | -0.44% | +28.55% | |
| 11 | OCUL | Ocular Therapeutix Inc | Stock-Other | 2.51% | +3.48% | +199.60% | |
| 12 | MGTX | MeiraGTx Holdings plc | Stock-Other | 2.51% | +3.41% | — | |
| 13 | AEM | Agnico Eagle Mines LTD | Stock-Materials | 2.15% | -1.38% | — | |
| 14 | KGC | Kinross Gold CORP | Stock-Materials | 1.98% | -1.20% | — | |
| 15 | EQX | Equinox Gold CORP | Stock-Other | 1.61% | — | — | |
| 16 | FNV | Franco-nevada CORP | Stock-Materials | 1.49% | -0.67% | — | |
| 17 | SKE | Skeena Resources LTD | Stock-Other | 1.28% | — | +713.18% | |
| 18 | MQ8 | Mag Silver CORP | Stock-Other | 1.15% | — | -38.18% | |
| 19 | SLV | Ishares Silver Trust | ETF-Commodities | 1.09% | — | +64.95% | |
| 20 | BAH | Booz Allen Hamilton Holdings | Stock-Industrials | 1.02% | +2.62% | — | |
| 21 | V | Visa Inc-class A Shares | Stock-Financials | 0.64% | — | — | |
| 22 | PM | Philip Morris International | Stock-Consumer Staples | 0.58% | +0.09% | — | |
| 23 | ITA | Ishares U.s. Aerospace & Def | ETF-Other | 0.55% | +0.10% | — | |
| 24 | NOC | Northrop Grumman CORP | Stock-Industrials | 0.55% | -0.20% | — | |
| 25 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.52% | — | — | |
| 26 | RGLD | Royal Gold Inc | Stock-Materials | 0.51% | -1.58% | — | |
| 27 | DEO | Diageo Plc-sponsored Adr | Stock-Consumer Staples | 0.46% | — | — | |
| 28 | CVS | Cvs Health CORP | Stock-Healthcare | 0.44% | — | — | |
| 29 | AGI | Alamos Gold Inc-class A | Stock-Materials | 0.42% | -0.38% | -48.75% | |
| 30 | WPM | Wheaton Precious Metals CORP | Stock-Materials | 0.37% | -0.13% | -79.17% | |
| 31 | NEWP | New Pacific Metals CORP | Stock-Other | 0.35% | -0.02% | — | |
| 32 | SIL1EUR | Silvercrest Metals Inc | Stock-Other | 0.27% | — | -87.23% | |
| 33 | ✓ | Orgenesis, Inc. | Stock-Other | 0.14% | -0.01% | -90.00% | |
| 34 | CRDL | Cardiol Therapeutics Inc-a | Stock-Other | 0.10% | -0.07% | EXIT | |
| 35 | IRD | Opus Genetics Inc | Stock-Other | 0.06% | — | — | |
| 36 | GRAL | Grail Inc | Stock-Healthcare | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | APLT | Applied Therapeutics Inc | +4.4% | — | Unchanged |
| 2 | AGI | Alamos Gold Inc-class A | +3.2% | -48.75% | Trim |
| 3 | MGTX | MeiraGTx Holdings plc | +2.4% | NEW | New buy |
| 4 | OCUL | Ocular Therapeutix Inc | +1.5% | +199.60% | Add |
| 5 | ALDX | Aldeyra Therapeutics Inc | +1.5% | — | Unchanged |
| 6 | ✓ | Hookipa Pharma | +1.1% | -90.00% | Trim |
| 7 | SKE | Skeena Resources LTD | +1.1% | +713.18% | Add |
| 8 | VRNA | Verona Pharma PLC - Adr | +0.7% | — | Unchanged |
| 9 | SEA1EUR | Seabridge Gold Inc | +0.2% | +28.55% | Add |
| 10 | SLV | Ishares Silver Trust | +0.2% | +64.95% | Add |
| 11 | GRAL | Grail Inc | — | NEW | New buy |
| 12 | IRD | Opus Genetics Inc | 0% | — | Unchanged |
| 13 | CRDL | Cardiol Therapeutics Inc-a | -0.1% | — | Unchanged |
| 14 | NOC | Northrop Grumman CORP | -0.1% | — | Unchanged |
| 15 | PM | Philip Morris International | -0.1% | — | Unchanged |
| 16 | MREO | Mereo Biopharma Group Pl-adr | -0.1% | — | Unchanged |
| 17 | ✓ | Orgenesis, Inc. | -0.1% | -90.00% | Trim |
| 18 | DEO | Diageo Plc-sponsored Adr | -0.1% | — | Unchanged |
| 19 | ITA | Ishares U.s. Aerospace & Def | -0.2% | — | Unchanged |
| 20 | RGLD | Royal Gold Inc | -0.2% | — | Unchanged |
| 21 | CVS | Cvs Health CORP | -0.2% | — | Unchanged |
| 22 | NEWP | New Pacific Metals CORP | -0.2% | — | Unchanged |
| 23 | BHVN | Biohaven Ltd. | -0.2% | — | Unchanged |
| 24 | V | Visa Inc-class A Shares | -0.2% | — | Unchanged |
| 25 | BAH | Booz Allen Hamilton Holdings | -0.4% | — | Unchanged |
| 26 | AEM | Agnico Eagle Mines LTD | -0.4% | — | Unchanged |
| 27 | EQX | Equinox Gold CORP | -0.4% | — | Unchanged |
| 28 | KGC | Kinross Gold CORP | -0.6% | — | Unchanged |
| 29 | FNV | Franco-nevada CORP | -0.6% | — | Unchanged |
| 30 | SIL | Global X Silver Miners ETF | -1% | EXIT | Sold out |
| 31 | GLD | Spdr Gold Shares | -1% | — | Unchanged |
| 32 | MQ8 | Mag Silver CORP | -1.1% | -38.18% | Trim |
| 33 | ✓ | Entera Bio LTD | -1.4% | — | Unchanged |
| 34 | WPM | Wheaton Precious Metals CORP | -1.8% | -79.17% | Trim |
| 35 | ALT | Altimmune Inc | -1.8% | — | Unchanged |
| 36 | ✓ | Avadel Pharmaceuticals PLC ADR | -2% | — | Unchanged |
| 37 | SIL1EUR | Silvercrest Metals Inc | -2.3% | -87.23% | Trim |
According to official SEC Form 13F filings, Knoll Capital Management, LLC reported a total U.S. public equity portfolio value of $179.3M across 36 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including APLT, BHVN, ALDX) accounted for 71.4% of total reported equity market value during Q3 2024.
Top New Position Initiated
MGTX
市值: $5.2M
Top Position Liquidated / Trimmed
SIL
前期市值: $1.4M
During Q3 2024, Knoll Capital Management, LLC's top holdings by market value included APLT (22.8%)、BHVN (17.1%)、ALDX (14.2%). The largest single position, APLT, represented 22.8% of total portfolio value.
In Q3 2024, Knoll Capital Management, LLC made 13 total portfolio adjustments, initiating 2 new buys, adding to 4 positions, trimming 6 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.